Health and Wellness

The Multi-Billion-Dollar Battle For Metsera

The ongoing battle between Novo Nordisk and Pfizer for the acquisition of Metsera, a company specializing in treatments for obesity and diabetes, has taken a dramatic turn this week. Novo

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.

Lasted Health and Wellness

New Study Reveals That Daytime Naps May Be A Sign Of Serious Health Problems

Excessive napping may be a sign of more serious metabolic health issues.gettyDaytime naps, or "power-sleeps," have long been embraced across

Nancy Cox, a CDC veteran and stalwart in global flu research, dies at 77

Nancy Cox, a renowned figure in influenza research for many years, has passed away. She led the influenza team at

Concierge Medicine Was Built For The Few. Here’s How To Open It To The Many

Senior woman teleconsulting from home. (Photo by: BSIP/Universal Images Group via Getty Images)Universal Images Group via Getty ImagesConcierge medicine is

FDA fast-tracks review of new psychedelic mental health treatments

Damian Garde is a reporter at large, live and feature journalism, covering the global drug industry and contributing to STAT’s

New Antibody Drugs Target Disease From Within

Antibodies can now be re-engineered to work inside cells, not just on their surface, using AI-guided redesign of their binding

Big Catch-Up campaign targets childhood vaccines

Stay informed on health and medicine with STAT’s free newsletter, Morning Rounds, delivered every weekday. Sign up here. Tomorrow marks

Burnout in Medicine Is Still Prevalent, With Emergency Medicine Leading

The burnout crisis in healthcare continues to escalate.gettyA recent report reveals that while physician burnout is easing in some areas,

Trump closes first round of drug price negotiations with Regeneron deal

WASHINGTON — President Trump announced a significant drug pricing agreement with Regeneron on Thursday, marking the conclusion of the 17